Atopica logo
ATOPICA® MODIFIED (cyclosporine capsules, USP)

A proven product for atopic dermatitis for dogs.

It targets the cause of the problem to help reduce the incessant scratching, rubbing and licking.

Atopic Dermatitis:

  • Is a lifelong condition.1
  • Can be seasonal or year-round.1
  • Is the second most common cause of itching in dogs.2

ATOPICA® (cyclosporine capsules, USP) MODIFIED:

  • Is the first medication specifically approved for the control of chronic atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg).
  • Effectively relieves itchiness and reduces skin lesions.
  • Provides proven long-term relief.
  • 98% of pet owners would recommend to friends.3

If your dog is constantly scratching or licking, it may be suffering from atopic dermatitis. To help your veterinarian evaluate your dog, click on the link below to take a 1-minute canine atopic dermatitis quiz. Print the results and bring them to your appointment.

IMPORTANT SAFETY INFORMATION FOR DOGS - ATOPICA® (cyclosporine capsule, USP) MODIFIED: For use only in dogs. Keep this and all drugs out of reach of children. Capsules should not be broken or opened. Wear gloves during administration and wash hands after. Do not use Atopica in dogs with a history of neoplasia, reproducing dogs, or dogs with a hypersensitivity to cyclosporine. Atopica is a systemic immunosuppressant that may increase the susceptibility to infection and the development of neoplasia. Gastrointestinal problems and gingival hyperplasia may occur at the initial recommended dose. Safety and effectiveness has not been established in dogs less than 6 months or 4 lbs. Use with caution in dogs with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 enzyme system. The most common adverse events are vomiting and diarrhea. Please see product insert for full prescribing information.

ATOPICA® (cyclosporine capsules, USP) MODIFIED is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds.


1. Scott DW, Miller Jr WH, Griffin CE. Skin immune system and allergic skin disease. In: Muller GH, Scott DW, Kirk RW, et al, eds. Muller and Kirk’s Small Animal Dermatology. 6th ed. Philadelphia, PA: Saunders; 2001:543–666.

2. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology. 81 (2001) 147-151.

3. PetConnect Survey, October 2013.